Cite
HARVARD Citation
Sandborn, W. et al. (n.d.). A202 TOFACITINIB FOR THE TREATMENT OF ULCERATIVE COLITIS: UP TO 5.4 YEARS OF SAFETY DATA FROM GLOBAL CLINICAL TRIALS. Journal of the Canadian Association of Gastroenterology. pp. 396-397. [Online].